Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Hamostaseologie|February 19, 2025
Guidance-Based Appropriateness of Hemostasis Testing in the Acute SettingLuigi Devis, Deepa J Arachchillage, Michael Hardy, et al.
Thrombosis and Haemostasis|November 18, 2025
Laboratory Monitoring of UFH in Different Settings (DEXHEP Study): Association between Anti-Xa Levels, Platelet Factor 4 (PF4) Plasma Levels and Dextran SulfatePhilippe Savard, Emmanuel Curis, Isabelle Gouin-Thibault, et al.
Digital Health|April 29, 2025
Anti-factor Xa during unfractionated heparin therapy in critically ill patients: Development of prediction models using machine learningBoris Delange, Guillaume Bouzillé, Pauline Guillot, et al.
Thrombosis Research|November 12, 2019
Potential usefulness of activated charcoal (DOAC remove®) for dRVVT testing in patients receiving Direct Oral AntiCoagulantsGeorges Jourdi, Maxime Delrue, Alain Stepanian, et al.
Clinical Pharmacokinetics|January 3, 2024
Factors Influencing Unfractionated Heparin Pharmacokinetics and Pharmacodynamics During a Cardiopulmonary BypassAudrick Gibert, Julien Lanoiselée, Isabelle Gouin-Thibault, et al.
Thrombosis Research|October 24, 2021
Apixaban and rivaroxaban in obese patients treated for venous thromboembolism: Drug levels and clinical outcomesAlice Ballerie, Rémi Nguyen Van, Karine Lacut, et al.
Intensive Care Medicine|July 13, 2022
Bleeding and thrombotic events in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a nationwide cohort studyAlexandre Mansour, Erwan Flecher, Matthieu Schmidt, et al.
Research and Practice in Thrombosis and Haemostasis|August 18, 2025
Fibrinography and thrombography (thrombodynamics-4D) in atrial fibrillation assessment of direct oral anticoagulants in geriatrics patients aged 80 years and older receiving direct oral anticoagulant therapyGeoffrey Foulon-Pinto, Georges Jourdi, Maxime Delrue, et al.
Thrombosis and Haemostasis|December 17, 2013
A model predicting fluindione dose requirement in elderly inpatients including genotypes, body weight, and amiodaroneCaroline Moreau, Eric Pautas, Charlotte Duverlie, et al.
British Journal of Anaesthesia|February 4, 2026
Optimising protamine dosing for heparin reversal after cardiopulmonary bypass: a population pharmacokinetic-pharmacodynamic studyJulien Lanoiselée, Audrick Gibert, Isabelle Gouin-Thibault, et al.
Pageof 10